Citation:Lambertini M, Moore HCF, Leonard RCF, Loibl S, Munster P, Bruzzone M, et al 2018

From Cancer Guidelines Wiki

Citation


Lambertini M, Moore HCF, Leonard RCF, Loibl S, Munster P, Bruzzone M, et al. Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data. J Clin Oncol 2018 Jul 1;36(19):1981-1990 Available from: http://www.ncbi.nlm.nih.gov/pubmed/29718793.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Ovarian suppression during chemotherapyDr Wanyuan Cui MBBS BMEDSCI FRACPcompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:In female cancer patients does ovarian suppression with gonadotropin releasing hormone (GnRH) analogues or antagonists during chemotherapy reduce the risk of primary ovarian insufficiency?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:In female cancer patients does ovarian suppression with gonadotropin releasing hormone (GnRH) analogues or antagonists during chemotherapy reduce the risk of primary ovarian insufficiency?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. Ovarian suppression with GnRH analogues